Literature DB >> 27659337

A novel mutation in the AGXT gene causing primary hyperoxaluria type I: genotype-phenotype correlation.

Saoussen M'Dimegh1, Cécile Aquaviva-Bourdain, Asma Omezzine, Ibtihel M'Barek, Geneviéve Souche, Dorsaf Zellama, Kamel Abidi, Abdelattif Achour, Tahar Gargah, Saoussen Abroug, Ali Bouslama.   

Abstract

Primary hyperoxaluria type I (PH1) is an autosomal recessive metabolic disorder caused by inherited mutations in the AGXT gene encoding liver peroxisomal alanine : glyoxylate aminotransferase (AGT) which is deficient or mistargeted to mitochondria. PH1 shows considerable phenotypic and genotypic heterogeneity. The incidence and severity of PH1 varies in different geographic regions. DNA samples of the affected members from two unrelated Tunisian families were tested by amplifying and sequencing each of the AGXT exons and intron-exon junctions. We identified a novel frameshift mutation in the AGXT gene, the c.406_410dupACTGC resulting in a truncated protein (p.Gln137Hisfs*19). It is found in homozygous state in two nonconsanguineous unrelated families from Tunisia. These molecular findings provide genotype/phenotype correlations in the intrafamilial phenotypic and permit accurate carrier detection, and prenatal diagnosis. The novel p.Gln137Hisfs*19 mutation detected in our study extend the spectrum of known AGXT gene mutations in Tunisia.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27659337     DOI: 10.1007/s12041-016-0676-4

Source DB:  PubMed          Journal:  J Genet        ISSN: 0022-1333            Impact factor:   1.166


  26 in total

Review 1.  Nonsense-mediated mRNA decay in health and disease.

Authors:  P A Frischmeyer; H C Dietz
Journal:  Hum Mol Genet       Date:  1999       Impact factor: 6.150

2.  Mixed origin of the current Tunisian population from the analysis of Alu and Alu/STR compound systems.

Authors:  Wifak El Moncer; Esther Esteban; Raoudha Bahri; Magdalena Gayà-Vidal; Robert Carreras-Torres; Georgios Athanasiadis; Pedro Moral; Hassen Chaabani
Journal:  J Hum Genet       Date:  2010-09-30       Impact factor: 3.172

3.  Homozygosity haplotype allows a genomewide search for the autosomal segments shared among patients.

Authors:  Hitoshi Miyazawa; Masaaki Kato; Takuya Awata; Masakazu Kohda; Hiroyasu Iwasa; Nobuyuki Koyama; Tomoaki Tanaka; Shunei Kyo; Yasushi Okazaki; Koichi Hagiwara
Journal:  Am J Hum Genet       Date:  2007-05-02       Impact factor: 11.025

4.  Primary hyperoxaluria: report of an Italian family with clear sex conditioned penetrance.

Authors:  G Mandrile; A Robbiano; D F Giachino; R Sebastiano; E Dondi; R Fenoglio; P Stratta; M R Caruso; M Petrarulo; M Marangella; M De Marchi
Journal:  Urol Res       Date:  2008-11-05

Review 5.  Primary hyperoxalurias: disorders of glyoxylate detoxification.

Authors:  Eduardo Salido; Angel L Pey; Rosa Rodriguez; Victor Lorenzo
Journal:  Biochim Biophys Acta       Date:  2012-03-14

6.  Variable presentation of primary hyperoxaluria type 1 in 2 patients homozygous for a novel combined deletion and insertion mutation in exon 8 of the AGXT gene.

Authors:  C von Schnakenburg; S A Hulton; D V Milford; H P Roper; G Rumsby
Journal:  Nephron       Date:  1998       Impact factor: 2.847

Review 7.  Primary hyperoxaluria.

Authors:  Víctor Lorenzo; Armando Torres; Eduardo Salido
Journal:  Nefrologia       Date:  2014-04-30       Impact factor: 2.033

8.  Functional synergism between the most common polymorphism in human alanine:glyoxylate aminotransferase and four of the most common disease-causing mutations.

Authors:  M J Lumb; C J Danpure
Journal:  J Biol Chem       Date:  2000-11-17       Impact factor: 5.157

9.  Peroxisomal alanine:glyoxylate aminotransferase deficiency in primary hyperoxaluria type I.

Authors:  C J Danpure; P R Jennings
Journal:  FEBS Lett       Date:  1986-05-26       Impact factor: 4.124

Review 10.  Molecular aetiology of primary hyperoxaluria and its implications for clinical management.

Authors:  Christopher J Danpure; Gill Rumsby
Journal:  Expert Rev Mol Med       Date:  2004-01-09       Impact factor: 5.600

View more
  3 in total

1.  Human MiR-4660 regulates the expression of alanine-glyoxylate aminotransferase and may be a biomarker for idiopathic oxalosis.

Authors:  Xin Tu; Yuanyuan Zhao; Qianqian Li; Xiao Yu; Yang Yang; Shumei Shi; Zuochuan Ding; Yan Miao; Zhimiao Zou; Xinqiang Wang; Jipin Jiang; Dunfeng Du
Journal:  Clin Exp Nephrol       Date:  2019-03-09       Impact factor: 2.801

2.  Genetics and genomic medicine in Tunisia.

Authors:  Houda Elloumi-Zghal; Habiba Chaabouni Bouhamed
Journal:  Mol Genet Genomic Med       Date:  2018-03       Impact factor: 2.183

3.  Clinical analysis of 13 children with primary hyperoxaluria type 1.

Authors:  Jin-Ai Lin; Xin Liao; Wenlin Wu; Lixia Xiao; Longshan Liu; Jiang Qiu
Journal:  Urolithiasis       Date:  2021-03-15       Impact factor: 3.436

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.